Senior Manager, Corporate Portfolio & M&A

Fresenius Kabi USA, LLC; Fargo (ND); Remoto; USD 138.000 - 150.000; Tempo pieno

Descrizione del lavoro

Fresenius Kabi USA, LLC seeks a Manager of Corporate Portfolio and M&A to drive inorganic growth and strategic initiatives across the corporate portfolio. The role collaborates with global teams to advance due diligence, business cases, and board approvals.

The position offers regular travel to Lake Zurich, IL, with a focus on healthcare, MedTech, and biopharma segments, and includes a performance-based bonus and comprehensive benefits.

Competenze

• Bachelor's degree in a scientific/technical/finance field required; MBA strongly preferred.
• 5+ years in BD, M&A, strategy or analytics; at least 2 years healthcare experience.
• Strong understanding of financial statements and their business impact.
• Demonstrated success in a complex, matrix organization.
• Excellent verbal and written communication and presentation skills.
• Willingness to travel up to 15%, including international travel.

Mansioni

• Analyze markets, segments, and companies/assets for inorganic growth, with focus on nutrition, MedTech, and biopharma.
• Lead projects with cross-functional teams through due diligence, business case and board approvals.
• Prepare pitch documents for management to support prioritization of targets.
• Manage strategic portfolio analyses and evaluations of new business areas and scenarios.
• Build valuations using DCF, NPV, and precedents.

Conoscenze

Financial analysis

Presentation skills

Strategic thinking

Communication

Formazione

Bachelor's degree in scientific/technical/finance field

MBA

Strumenti

Excel

PowerPoint

Word

Descrizione del lavoro

Fresenius Kabi USA, LLC seeks a Manager of Corporate Portfolio and M&A to drive inorganic growth and strategic initiatives across the corporate portfolio. The role collaborates with global teams to advance due diligence, business cases, and board approvals.

The position offers regular travel to Lake Zurich, IL, with a focus on healthcare, MedTech, and biopharma segments, and includes a performance-based bonus and comprehensive benefits.